IP Library › Granted Patent US 10,603,419
Granted Patent B2
US 10,603,419 · App. 15/046,152 · Granted Mar 31, 2020

Systems and methods for increasing convective clearance of undesired particles in a microfluidic device

Inventors: Joseph L. Charest (Cambridge, MA); Martin Nohilly (Murray Hill, NJ); Christopher Dibiasio (Stoughton, MA); Jeffrey T. Borenstein (Newton, MA); Mark Laurenzi (Mountain Lakes, NJ); Jonathan Wilson (Mattapoisett Center, MA)
Assignee: The Charles Stark Draper Laboratories, Inc.
A61M1/1603A61M1/16A61M1/1601A61M1/1631A61M1/1694A61M1/34A61M1/3403A61M1/3434A61M1/3437A61M1/3441B01D61/28B01D63/088B81B7/0009A61M2202/0413A61M2205/0244A61M2205/3331A61M2205/3334A61M2230/207
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,603,419
App. No.
15/046,152
Granted
Mar 31, 2020
Kind
B2
Abstract

A microfluidic device for increasing convective clearance of particles from a fluid is provided. In some implementations, described herein the microfluidic device includes multiple layers that each define infusate, blood, and filtrate channels. Each of the channels have a pressure profile. The device can also include one or more pressure control features. The pressure control feature controls a difference between the pressure profiles along a length of the device. For example, the pressure control feature can control the difference between the pressure profile of the filtrate channel and the pressure profile of the blood channel. In some implementations, the pressure control feature controls the pressure difference between two channels such that the difference varies along the length of the channels by less than 50% of the pressure difference between the channels at the channels' inlets.

Claims (27)

1. A microfluidic device comprising:

a first layer defining an infusate channel, the infusate channel having a first pressure profile with a first slope along a length of the infusate channel;

a second layer defining a blood channel in fluidic communication with the infusate channel, the blood channel having a second pressure profile with a second slope along a length of the blood channel;

a filtrate layer defining a filtrate channel in fluidic communication with the blood channel, the filtrate channel having a third pressure profile with a third slope along a length of the filtrate channel;

a first interchannel flow barrier separating the infusate channel and the blood channel, wherein the first interchannel flow barrier includes a plurality of openings defined through the first interchannel flow barrier, allowing passage of fluid from the infusate channel into the blood channel;

a second interchannel flow barrier separating the filtrate channel and the blood channel;

a first controllable flow control device along a length of the filtrate channel configured to actively control the third slope of the third pressure profile along the length of the filtrate channel relative to the second slope of the second pressure profile along the length of the blood channel;

a second controllable flow control device configured to actively control the first slope of the first pressure profile along the length of the infusate channel relative to the second slope of the second pressure profile along the length of the blood channel; and

a control system configured to modify a state of the first controllable flow control device and the second controllable flow control device such that the first slope of the first pressure profile along the length of the infusate channel is substantially parallel to the third slope of the third pressure profile along the length of the filtrate channel.

2. The microfluidic device of claim 1 , further comprising at least one pressure sensor coupled to the control system, wherein the control system is configured to modify the state of the first or second controllable flow control device responsive to an output of the at least one pressure sensor.

3. The microfluidic device of claim 1 , wherein the first and second controllable flow control devices are one of a recirculating pump, a proportional valve, a diaphragm chamber, or an outflow pump.

4. The microfluidic device of claim 1 , wherein the control system is configured to control the first and second controllable flow control devices such that the first pressure profile is substantially parallel to the second pressure profile.

5. The microfluidic device of claim 1 , wherein the control system is configured to cause the first controllable flow control device to achieve a state such that the slope of the third pressure profile is greater than the slope of the second pressure profile.

6. The microfluidic device of claim 1 , wherein the control system is configured to cause the first controllable flow control device to achieve a state such that the slope of the third pressure profile is less than the slope of the second pressure profile.

7. The microfluidic device of claim 1 , comprising a third controllable flow control device configured to, along with the first controllable flow control device, actively control the slope of the third pressure profile along the length of the filtrate channel relative to the slope of the second pressure profile along the length of the blood channel.

8. The microfluidic device of claim 1 , wherein the blood channel has a height in the range of about 50 μm to about 500 μm, a width in the range of about 50 μm to about 900 μm, and a length in the range of about 3 cm to about 30 cm.

9. The microfluidic device of claim 1 , wherein the second interchannel flow barrier comprises a membrane.

10. The microfluidic device of claim 1 , wherein the second interchannel flow barrier is a sterility barrier.

11. The microfluidic device of claim 1 , wherein the first interchannel flow barrier further comprises a membrane located between the infusate channel and the blood channel.

12. The microfluidic device of claim 1 , wherein the second layer defines a plurality of blood channels.

13. The microfluidic device of claim 12 , wherein the plurality of blood channels are in fluid communication with the infusate channel through the plurality of openings in the first interchannel flow barrier.

14. The microfluidic device of claim 13 , wherein the plurality of openings through the first interchannel flow barrier are positioned sequentially along the length of the infusate channel, and each of the openings spans across all of the blood channels in the second layer.

15. The microfluidic device of claim 14 , wherein the openings through the first interchannel flow barrier have a pitch along the length of the infusate channel of between about 1 cm and 10 cm.

16. The microfluidic device of claim 14 , wherein the spacing of the openings through the first interchannel flow barrier decreases along the length of the infusate channel.

17. The microfluidic device of claim 14 , wherein the size of the openings through the first interchannel flow barrier increases along the length of the infusate channel.

18. The microfluidic device of claim 1 , wherein the first interchannel flow barrier comprises a substantially non-porous material through which the openings are defined.

19. The microfluidic device of claim 18 , wherein the first interchannel flow barrier includes a portion of the first layer defining a floor of the infusate channel.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2017
From: NOHILLY, MARTIN; LAURENZI, MARK; WILSON, JONATHAN
To: JOHNSON & JOHNSON INNOVATION LLC
Reel/Frame 041767/0967 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2017
From: CHAREST, JOSEPH L.; DIBIASIO, CHRISTOPHER; BORENSTEIN, JEFFREY T.
To: THE CHARLES STARK DRAPER LABORATORY, INC.
Reel/Frame 042107/0583 →
Continuity (5)
Continuation In Part 14832875 · Aug 21, 2015
Continuation In Part 13739701 · Jan 11, 2013
Continuation In Part 13739685 · Jan 11, 2013
Provisional Application 62040131 · Aug 21, 2014
Related Publication 20160158428A1 · Jun 9, 2016